Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)

v3.21.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Common Stock
Paid in Capital
Retained Earnings/Accumulated (Deficit)
Beginning Balances at Dec. 31, 2019 $ 42,065,916 $ 93,303 $ 40,329,502 $ 1,643,111
Beginning Balance, shares at Dec. 31, 2019   9,330,297    
Restricted stock grants issued   $ 259 (259)  
Restricted stock grants issued, Shares   25,905    
Stock-based compensation 29,162   29,162  
Net income (loss) (356,424)     (356,424)
Dividends (606,469)     (606,469)
Ending Balance at Mar. 31, 2020 41,132,185 $ 93,562 40,358,405 680,218
Ending Balance, shares at Mar. 31, 2020   9,356,202    
Beginning Balances at Dec. 31, 2019 42,065,916 $ 93,303 40,329,502 1,643,111
Beginning Balance, shares at Dec. 31, 2019   9,330,297    
Net income (loss) (41,444)      
Ending Balance at Sep. 30, 2020 40,301,458 $ 93,562 40,429,005 (221,109)
Ending Balance, shares at Sep. 30, 2020   9,356,202    
Beginning Balances at Mar. 31, 2020 41,132,185 $ 93,562 40,358,405 680,218
Beginning Balance, shares at Mar. 31, 2020   9,356,202    
Stock-based compensation 35,317   35,317  
Net income (loss) (22,144)     (22,144)
Dividends (608,154)     (608,154)
Ending Balance at Jun. 30, 2020 40,537,204 $ 93,562 40,393,722 49,920
Ending Balance, shares at Jun. 30, 2020   9,356,202    
Stock-based compensation 35,283   35,283  
Net income (loss) 337,124     337,124
Dividends (608,153)     (608,153)
Ending Balance at Sep. 30, 2020 40,301,458 $ 93,562 40,429,005 (221,109)
Ending Balance, shares at Sep. 30, 2020   9,356,202    
Beginning Balances at Dec. 31, 2020 $ 40,038,891 $ 93,431 40,455,409 (509,949)
Beginning Balance, shares at Dec. 31, 2020 9,343,118 9,343,118    
Restricted stock grants issued   $ 635 (635)  
Restricted stock grants issued, Shares   63,475    
Stock-based compensation $ 31,706   31,706  
Net income (loss) 411,247     411,247
Dividends (607,303)     (607,303)
Ending Balance at Mar. 31, 2021 39,874,541 $ 94,066 40,486,480 (706,005)
Ending Balance, shares at Mar. 31, 2021   9,406,593    
Beginning Balances at Dec. 31, 2020 $ 40,038,891 $ 93,431 40,455,409 (509,949)
Beginning Balance, shares at Dec. 31, 2020 9,343,118 9,343,118    
Net income (loss) $ 1,901,608      
Ending Balance at Sep. 30, 2021 $ 46,349,866 $ 107,086 46,766,712 (523,932)
Ending Balance, shares at Sep. 30, 2021 10,708,613 10,708,613    
Beginning Balances at Mar. 31, 2021 $ 39,874,541 $ 94,066 40,486,480 (706,005)
Beginning Balance, shares at Mar. 31, 2021   9,406,593    
Restricted stock grants issued   $ 123 (123)  
Restricted stock grants issued, Shares   12,300    
Issuance of common stock, net of expenses 6,184,684 $ 12,897 6,171,787  
Issuance of common stock, net of expenses, Shares   1,289,720    
Stock-based compensation 54,476   54,476  
Net income (loss) 861,299     861,299
Dividends (612,228)     (612,228)
Ending Balance at Jun. 30, 2021 46,362,772 $ 107,086 46,712,620 (456,934)
Ending Balance, shares at Jun. 30, 2021   10,708,613    
Stock-based compensation 54,092   54,092  
Net income (loss) 629,062     629,062
Dividends (696,060)     (696,060)
Ending Balance at Sep. 30, 2021 $ 46,349,866 $ 107,086 $ 46,766,712 $ (523,932)
Ending Balance, shares at Sep. 30, 2021 10,708,613 10,708,613